New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-male-breast-primary-histology | Version: 0.1.0 | |||
Active as of 2024-11-11 | Computable Name: canshare-who-male-breast-primary-histology | |||
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-male-breast-primary-histology |
Histologies used for male breast primaries (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 3. Fibroepithelial tumours and hamartomas of the breast, 4. Tumours of the nipple, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-who-male-breast-primary-histology
version: 1; Last updated: 2024-11-05 17:09:38+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct
where constraint = (^300141000210101 |New Zealand World Health Organization classification of tumors 5th edition breast fibroepithelial tumor and hamartoma histology reference set| OR ^300151000210103 |New Zealand World Health Organization classification of tumors 5th edition breast tumor of nipple histology reference set| OR ^300161000210100 |New Zealand World Health Organization classification of tumors 5th edition breast mesenchymal histology reference set| OR ^300191000210105 |New Zealand World Health Organization classification of tumors 5th edition male breast histology reference set| OR 74964007 |Other|) MINUS ^303021000210104 |New Zealand WHO classification of tumours (5th edition) breast benign histology reference set|
Generated Narrative: ValueSet canshare-who-male-breast-primary-histology
version: 1; Last updated: 2024-11-05 17:09:38+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 17 concepts
Code | System | Display - English (English, en) |
863926008 | http://snomed.info/sct | Angiosarcoma |
476441000210107 | http://snomed.info/sct | Atypical granular cell tumour |
71232009 | http://snomed.info/sct | Borderline phyllodes tumour |
295141000210101 | http://snomed.info/sct | Desmoid type fibromatosis |
115230008 | http://snomed.info/sct | Fibroepithelial neoplasm |
13238004 | http://snomed.info/sct | Granular cell tumour, malignant |
82711006 | http://snomed.info/sct | Infiltrating duct carcinoma |
1290860006 | http://snomed.info/sct | Inflammatory myofibroblastic tumour |
1163022006 | http://snomed.info/sct | Leiomyosarcoma |
1162815008 | http://snomed.info/sct | Liposarcoma |
87913009 | http://snomed.info/sct | Malignant phyllodes tumour |
301571000210108 | http://snomed.info/sct | Mesenchymal neoplasm |
301521000210109 | http://snomed.info/sct | Non-infiltrating intraductal carcinoma of breast |
74964007 | http://snomed.info/sct | Other |
2985005 | http://snomed.info/sct | Paget's disease, mammary |
285101000210103 | http://snomed.info/sct | Phyllodes tumour |
285111000210101 | http://snomed.info/sct | Postradiation angiosarcoma |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |